These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10699005)

  • 1. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of the LCx HIV RNA quantitative assay--a new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA.
    Troonen H; Grey H; Michel G
    Clin Chem Lab Med; 2002 Jul; 40(7):698-704. PubMed ID: 12241017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Erice A; Brambilla D; Bremer J; Jackson JB; Kokka R; Yen-Lieberman B; Coombs RW
    J Clin Microbiol; 2000 Aug; 38(8):2837-45. PubMed ID: 10921936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina.
    Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of human immunodeficiency virus viral load testing in Australia.
    Best SJ; Gust AP; Johnson EI; McGavin CH; Dax EM
    J Clin Microbiol; 2000 Nov; 38(11):4015-20. PubMed ID: 11060062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Sun R; Ku J; Jayakar H; Kuo JC; Brambilla D; Herman S; Rosenstraus M; Spadoro J
    J Clin Microbiol; 1998 Oct; 36(10):2964-9. PubMed ID: 9738051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilaboratory comparison of hepatitis C virus viral load assays.
    Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
    J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Nolte FS; Boysza J; Thurmond C; Clark WS; Lennox JL
    J Clin Microbiol; 1998 Mar; 36(3):716-20. PubMed ID: 9508301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.
    Pasquier C; Sandres K; Salama G; Puel J; Izopet J
    J Virol Methods; 1999 Aug; 81(1-2):123-9. PubMed ID: 10488770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA.
    Erali M; Hillyard DR
    J Clin Microbiol; 1999 Mar; 37(3):792-5. PubMed ID: 9986856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three current viral load assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Katsoulidou A; Papachristou E; Petrodaskalaki M; Sypsa V; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2004 Oct; 121(1):93-9. PubMed ID: 15350738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.